(Q45737847)

English

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers

scientific article published on 10 April 2001

Statements

Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers (English)
C Stevens
S Buchbinder
H Sheppard
D Stablein
J McNamara
J Flores
J L Excler
M Klein
R E Habib
A M Duliege
C Harro
L Corey
M Keefer
M Mulligan
P Wright
F Judson
K Mayer
D McKirnan
G Woody
National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET)
10 April 2001
1343-1352

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit